Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
ABOUT THIS PAGE
40
PharmaCompass offers a list of Idraparinux sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Idraparinux sodium manufacturer or Idraparinux sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Idraparinux sodium manufacturer or Idraparinux sodium supplier.
PharmaCompass also assists you with knowing the Idraparinux sodium API Price utilized in the formulation of products. Idraparinux sodium API Price is not always fixed or binding as the Idraparinux sodium Price is obtained through a variety of data sources. The Idraparinux sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Idraparinux sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Idraparinux sodium, including repackagers and relabelers. The FDA regulates Idraparinux sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Idraparinux sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Idraparinux sodium supplier is an individual or a company that provides Idraparinux sodium active pharmaceutical ingredient (API) or Idraparinux sodium finished formulations upon request. The Idraparinux sodium suppliers may include Idraparinux sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Idraparinux sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Idraparinux sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Idraparinux sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Idraparinux sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Idraparinux sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Idraparinux sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Idraparinux sodium suppliers with NDC on PharmaCompass.
Idraparinux sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Idraparinux sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Idraparinux sodium GMP manufacturer or Idraparinux sodium GMP API supplier for your needs.
A Idraparinux sodium CoA (Certificate of Analysis) is a formal document that attests to Idraparinux sodium's compliance with Idraparinux sodium specifications and serves as a tool for batch-level quality control.
Idraparinux sodium CoA mostly includes findings from lab analyses of a specific batch. For each Idraparinux sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Idraparinux sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Idraparinux sodium EP), Idraparinux sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Idraparinux sodium USP).
